Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 2, 2013, Pages 149-154

  Lamaziere, Antonin ^a   Wolf, Claude ^a   Barbe, Ullah ^a   Bausero, Pedro ^a   Visioli, Francesco ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Lipidomics; Liver; Omega 3 fatty acids; Phospholipids

Indexed keywords

ACYL COENZYME A DESATURASE; ACYL COENZYME A DESATURASE 1; FISH OIL; LINOLEOYL COENZYME A DESATURASE; OMEGA 3 FATTY ACID; STEAROYL COA DESATURASE 16; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ENZYME SUBSTRATE; FATTY ACID SYNTHESIS; GAS LIQUID CHROMATOGRAPHY; LIPID ANALYSIS; LIPID LIVER LEVEL; LIPIDOMICS; LIPOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RAT; SUPPLEMENTATION;

ANIMALS; FATTY ACID DESATURASES; FATTY ACIDS, OMEGA-3; LINOLEOYL-COA DESATURASE; LIPOGENESIS; LIVER; MALE; PHOSPHOLIPIDS; RATS; RATS, WISTAR; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STEAROYL-COA DESATURASE;

RATTUS;

EID: 84875803499     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.12.001     Document Type: Article

References (32)

1. Richard D., Bausero P., Schneider C., Visioli F. Polyunsaturated fatty acids and cardiovascular disease. Cell Mol. Life Sci. 2009, 66:3277-3288.
2. Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br. J. Clin. Pharmacol. 2012.
3. Calder P.C. The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability. Mol. Nutr. Food Res. 2012, 56:1073-1080.
4. Eckert G.P., Lipka U., Muller W.E. Omega-3 fatty acids in neurodegenerative diseases: focus on mitochondria. Prostaglandins Leukotrienes Essent. Fatty Acids 2012.
5. Li Y., Chen D. The optimal dose of omega-3 supplementation for non-alcoholic fatty liver disease. J. Hepatol. 2012.
6. Bechmann L.P., Hannivoort R.A., Gerken G., Hotamisligil G.S., Trauner M., Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 2012, 56:952-964.
7. Valenzuela R., Videla L.A. The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct. 2011, 2:644-648.
8. Lamaziere A., Richard D., Barbe U., Kefi K., Bausero P., Wolf C., et al. Differential distribution of DHA-phospholipids in rat brain after feeding: a lipidomic approach. Prostaglandins Leukotrienes Essent. Fatty Acids 2011, 84:7-11.
9. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-509.
10. Wolf C., Quinn P.J. Lipidomics in diagnosis of lipidoses. Subcell. Biochem. 2008, 49:567-588.
11. Wolf C., Quinn P.J. Lipidomics: practical aspects and applications. Prog. Lipid Res. 2008, 47:15-36.
12. Boutet E., El Mourabit H., Prot M., Nemani M., Khallouf E., Colard O., et al. Seipin deficiency alters fatty acid delta9 desaturation and lipid droplet formation in Berardinelli-Seip congenital lipodystrophy. Biochimie 2009, 91:796-803.
13. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
14. Quinn P.J., Rainteau D., Wolf C. Lipidomics of the red cell in diagnosis of human disorders. Methods Mol. Biol. 2009, 579:127-159.
15. Picq M., Chen P., Perez M., Michaud M., Vericel E., Guichardant M., et al. DHA metabolism: targeting the brain and lipoxygenation. Mol. Neurobiol. 2010, 42:48-51.
16. Peters B.S., Wierzbicki A.S., Moyle G., Nair D., Brockmeyer N. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial. Clin. Ther. 2012, 34:67-76.
17. Richard D., Wolf C., Barbe U., Kefi K., Bausero P., Visioli F. Docosahexaenoic acid down-regulates endothelial Nox 4 through a sPLA2 signalling pathway. Biochem. Biophys. Res. Commun. 2009, 389:516-522.
18. Garrel C., Alessandri J.M., Guesnet P., Al Gubory K.H. Omega-3 fatty acids enhance mitochondrial superoxide dismutase activity in rat organs during post-natal development. Int. J. Biochem. Cell Biol. 2012, 44:123-131.
19. Parker H.M., Johnson N.A., Burdon C.A., Cohn J.S., O'Connor H.T., George J. Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J. Hepatol. 2012, 56:944-951.
20. Xu J., Nakamura M.T., Cho H.P., Clarke S.D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. J. Biol. Chem. 1999, 274:23577-23583.
21. Yoshikawa T., Shimano H., Yahagi N., Ide T., Amemiya-Kudo M., Matsuzaka T., et al. Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. J. Biol. Chem. 2002, 277:1705-1711.
22. Sampath H., Ntambi J.M. Polyunsaturated fatty acid regulation of gene expression. Nutr. Rev. 2004, 62:333-339.
23. Liu X., Miyazaki M., Flowers M.T., Sampath H., Zhao M., Chu K., et al. Loss of stearoyl-CoA desaturase-1 attenuates adipocyte inflammation: effects of adipocyte-derived oleate. Arterioscler. Thromb. Vasc. Biol. 2010, 30:31-38.
24. Vuppalanchi R., Cummings O.W., Saxena R., Ulbright T.M., Martis N., Jones D.R., et al. Relationship among histologic, radiologic, and biochemical assessments of hepatic steatosis: a study of human liver samples. J. Clin. Gastroenterol. 2007, 41:206-210.
25. Samoilova E.V., Pirkova A.A., Prokazova N.V., Korotaeva A.A. Effects of LDL lipids on activity of group IIA secretory phospholipase A2. Bull. Exp. Biol. Med. 2010, 150:39-41.
26. Matsumoto T., Kobayashi T., Kamata K. Role of lyso phosphatidylcholine (LPC) in atherosclerosis. Curr. Med. Chem. 2007, 14:3209-3220.
27. Yang M., Chu E.M., Caslake M.J., Edelstein C., Scanu A.M., Hill J.S. Lipoprotein-associated phospholipase A2 decreases oxidized lipoprotein cellular association by human macrophages and hepatocytes. Biochim. Biophys. Acta 1801, 2010:176-182.
28. Adibhatla R.M., Hatcher J.F. Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders. Neurochem. Res. 2005, 30:15-23.
29. Bazan N.G., Rodriguez de Turco E.B., Gordon W.C. Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses: biochemical and autoradiographic studies. Can. J. Physiol. Pharmacol. 1993, 71:690-698.
30. Byrne C.D. Fatty liver: role of inflammation and fatty acid nutrition. Prostaglandins Leukotrienes Essent. Fatty Acids 2010, 82:265-271.
31. Shapiro H., Tehilla M., Attal-Singer J., Bruck R., Luzzatti R., Singer P. The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease. Clin. Nutr. 2011, 30:6-19.
32. Masterton G.S., Plevris J.N., Hayes P.C. Review article: omega-3 fatty acids-a promising novel therapy for non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2010, 31:679-692.